Kelly Timothy P - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kelly Timothy P
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-02-25
Sale
2026-02-27
4:01 pm
Caribou Biosciences Inc.CRBUKelly Timothy P
Chief Technology Officer
6,228$1.93$12,02073,125
(Direct)
View
2026-02-24
Sale
2026-02-24
8:54 pm
Caribou Biosciences Inc.CRBUKelly Timothy P
Chief Technology Officer
3,147$1.96$6,168281,853
(Direct)
View
2022-01-05
Sale
2022-01-12
4:05 pm
Homology Medicines Inc.FIXXKelly Timothy P
Chief Operating Officer
1,406$3.7801$5,3159,594
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2026-02-20
Option Award
2026-02-24
8:54 pm
N/A
2036-02-19
Caribou Biosciences Inc.CRBUKelly Timothy P
Chief Technology Officer
247,500$0281,853
(Direct)
View
2025-02-20
Option Award
2025-02-21
8:18 pm
N/A
2035-02-19
Caribou Biosciences Inc.CRBUKelly Timothy P
Chief Technology Officer
207,500$0207,500
(Direct)
View
2024-01-08
Option Award
2024-01-09
4:10 pm
N/A
2034-01-07
Caribou Biosciences Inc.CRBUKelly Timothy P
Chief Technology Officer
300,000$0300,000
(Direct)
View
2022-02-24
Option Award
2022-02-28
4:05 pm
N/A
2032-02-24
Homology Medicines Inc.FIXXKelly Timothy P
Chief Operating Officer
33,000$033,000
(Direct)
View
2022-01-01
Exercise
2022-01-12
4:05 pm
N/A
N/A
Homology Medicines Inc.FIXXKelly Timothy P
Chief Operating Officer
3,630$09,594
(Direct)
View